eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs).

Biotechnology

eFFECTOR Therapeutics

Steve Worland

Mark Densel

Gary Chiang

Sam Sperry

Doug Warner

Mike Byrnes

The leadership team at eFFECTOR Therapeutics has a history of experience in the finance industry, with members coming from companies such as Principia Biopharma, Alkahest, Inc., and Ocera Therapeutics. They also have a strong educational background, with members holding degrees in finance from Santa Clara University and California State University - East Bay.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at eFFECTOR Therapeutics

Board of Directors

CEO and Executive Team